Tag: disproportionality analysis

Using Statistical Tools to Detect AE Clusters in Clinical Trials

July 6, 2025

Using Statistical Tools to Detect AE Clusters in Clinical Trials Applying Statistical Tools for Adverse Event (AE) Cluster Detection in Clinical Trials Detecting adverse event (AE) clusters is a vital step in maintaining patient safety during clinical trials. Relying on anecdotal observations or manual AE reviews can delay the recognition of critical safety signals. Instead,…

Safety Reporting and Pharmacovigilance, Safety Signal Detection

What Constitutes a Safety Signal in Clinical Research

July 6, 2025

digi

What Constitutes a Safety Signal in Clinical Research Understanding What Constitutes a Safety Signal in Clinical Research In clinical research, protecting participants’ safety is paramount. One of the most critical elements of pharmacovigilance is the identification and evaluation of safety signals. But what exactly constitutes a safety signal? This tutorial provides a comprehensive overview of…

Safety Reporting and Pharmacovigilance, Safety Signal Detection

Safety Signal Detection in Pharmacovigilance: Comprehensive Methods and Best Practices

April 28, 2025

digi No Comments

Safety Signal Detection in Pharmacovigilance: Comprehensive Methods and Best Practices Mastering Safety Signal Detection in Pharmacovigilance and Clinical Trials Safety Signal Detection is a cornerstone of modern pharmacovigilance, essential for identifying potential risks associated with drug therapies during clinical development and post-marketing. Through proactive signal detection, pharmaceutical companies protect patient safety, maintain regulatory compliance, and…

Safety Reporting and Pharmacovigilance, Safety Signal Detection